ApoCell enters into strategic alliances with pharmaceutical and biotechnology companies and contract research organizations, to jointly work on identifying biomarkers that can be used for optimizing drug efficacy, and ultimately validated for companion diagnostics. Our biomarker expertise can be leveraged to efficiently and economically facilitate drug development at any stage.
We look to our partnerships to provide potential downstream economics while preserving growth opportunities in the future. The company is routinely selected by our strategic partners to serve as an accredited laboratory or key technology provider for various targeted therapeutics and immuno-oncology programs. We are open to partnering where we can have the most beneficial impact in improving the lives of patients with debilitating diseases.